About Good Returns  |  Advertise  |  Contact Us  |  Terms & Conditions  |  RSS Feeds Other Sites:   depositrates.co.nz  |   landlords.co.nz
Last Article Uploaded: Thursday, September 21st, 8:24PM
Check out GoodReturns TV now! Dismiss
Latest Headlines

AIA expands cancer benefit reach

AIA is offering its cancer treatment benefit as an optional addition to more of its policies.

Monday, August 28th 2017, 6:00AM

The benefit, which funds Medsafe-approved medicines not funded by Pharmac, had previously only been available as an add-on to AIA’s Real Trauma policies.

This has now been expanded to include Real life and total permanent disability policies.

“AIA New Zealand was the first to see a gap in the market for the Cancer Treatment Benefit, which we launched in March this year. Sales to date have been very encouraging,”  David Savidan, AIA New Zealand’s head of marketing and product, said.

“Detecting cancer early, and getting access to the new generation of proven immunotherapy medicines, can greatly improve a person’s chances of surviving cancer.”

A course of one of the new generation of immunotherapy drugs such as Yervoy (for previously-treated or newly-diagnosed advanced melanoma cases) or the advanced prostate cancer drug Provenge, can cost between tens to hundreds of thousands of dollars per patient.

“AIA New Zealand’s cancer treatment benefit gives immediate access to specialists and diagnostic tools, as well as the leading medicines, whether they are publicly-funded or not,” Savidan said.

The benefit provides cover for specialist visits and diagnostic tests for the diagnosis of cancer. If cancer is present, it provides access to both Pharmac and non-Pharmac treatments and the latest cancer immunotherapy medicines, up to $500,000 per year.

Tags: AIA

« Newpark considers being a licensed dealer groupnib grows market share and distribution »

Special Offers

Comments from our readers

No comments yet

Sign In to add your comment



Printable version  


Email to a friend
Strategy Thoughts
News Bites
Latest Comments
  • Sovereign sold
    “@Murray - I recommended to AIA Senior Management in 1999 that they buy Sovereign. Got nowhere at all. Different times, different...”
    14 minutes ago by dcwhyte
  • Sovereign sold
    “@Mr Slater I don't think so. An Aussie story I saw said the price was 16.9 times 2017-18 pro forma earnings. That story...”
    5 hours ago by Murray Weatherston
  • Sovereign sold
    “It looks like AIA may have now joined the Big End Of Town. Hopefully that isn't a negative thing and they continue to act...”
    6 hours ago by Comprehensive Planner
  • Sovereign sold
    “Large financial institutions are divesting themselves of wealth management capabilities presenting threats and opportunities...”
    6 hours ago by Pragmatic
  • Sovereign sold
    “Murray I hope it wasn't a case of 'buy one get one free'?...”
    7 hours ago by Mr Slater
Subscribe Now

Cover Notes - Specific news aimed at risk advisers

Previous News


Most Commented On
About Us  |  Advertise  |  Contact Us  |  Terms & Conditions  |  Privacy Policy  |  RSS Feeds  |  Letters  |  Archive  |  Toolbox
Site by Web Developer and eyelovedesign.com